Peracetic Acid Industry Report 2023: Market Poised for
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Dynamics Shaping. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The
/PRNewswire/ -- The "Global Industrial Robotics Market Outlook to 2027" report has been added to ResearchAndMarkets.com's offering. The industrial sector is...
50+ active players in the domain working on 50+ pipeline therapies. Key Respiratory Syncytial Virus Infection Pipeline therapies such as RSV-F, V-306, CodaVax-RSV, mRNA-1345, MV-012-968, RV521, BARS13, EDP-938, MEDI8897, RSV MAT, RSVpreF, JNJ-53718678, RSV vaccine, ALVR106, V-306, CodaVax-RSV, mRNA-1345, Research program: sirtuin targeted therapeutics for respiratory viral infections and others are under different phases of clinical trials for Respiratory Syncytial Virus (RSV). Virometix, ReViral Ltd, Advaccine (Suzhou) Biopharmaceuticals Co., Ltd. Codagenix, Inc, ModernaTX, Inc., Meissa Va...